Kirsten Axelson presents during the session titled “How Global Pricing Dynamics are Shaping Developer Market Access Strategies: Current and Future Trends” moderated by Rajini Jayasuriya.
For more information on this event, click here.
Rare disease PMA trends in France: Price achieved vs. disease prevalence
In this installment, we examine the relationship between launch prices in France and disease prevalence as reported in the Haute Autorité de Santé assessments.